Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders??? Equity

v3.22.2
Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Previously Reported
Retroactive application of reverse recapitalization
Common Stock
Common Stock
Previously Reported
Common Stock
Retroactive application of reverse recapitalization
Additional Paid-in Capital
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Retroactive application of reverse recapitalization
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Previously Reported
Accumulated Deficit
Accumulated Deficit
Previously Reported
Beginning balance (in shares) at Dec. 31, 2020       66,637 1 66,636              
Balance, beginning of period at Dec. 31, 2020 $ 34,141 $ 34,141 $ 0 $ 7 $ 0 $ 7 $ 59,168 $ 59,175 $ (7) $ (206) $ (206) $ (24,828) $ (24,828)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Foreign currency translation adjustment 39                 39      
Stock-based compensation 139           139            
Net loss (4,175)                     (4,175)  
Ending balance (in shares) at Mar. 31, 2021       66,637                  
Balance, end of period at Mar. 31, 2021 30,144     $ 7     59,307     (167)   (29,003)  
Beginning balance (in shares) at Dec. 31, 2020       66,637 1 66,636              
Balance, beginning of period at Dec. 31, 2020 34,141 34,141 0 $ 7 $ 0 $ 7 59,168 59,175 (7) (206) (206) (24,828) (24,828)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Foreign currency translation adjustment 14                        
Net loss (80,018)                        
Net unrealized loss on marketable securities 0                        
Ending balance (in shares) at Jun. 30, 2021       87,085                  
Balance, end of period at Jun. 30, 2021 144,814     $ 9     249,843     (192)   (104,846)  
Beginning balance (in shares) at Mar. 31, 2021       66,637                  
Balance, beginning of period at Mar. 31, 2021 30,144     $ 7     59,307     (167)   (29,003)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Foreign currency translation adjustment (25)                 (25)      
Stock-based compensation 139           139            
Net loss (75,843)                     (75,843)  
Merger and PIPE financing (in shares)       20,448                  
Merger and PIPE financing     $ 190,399     $ 2     $ 190,397        
Net unrealized loss on marketable securities 0                        
Ending balance (in shares) at Jun. 30, 2021       87,085                  
Balance, end of period at Jun. 30, 2021 144,814     $ 9     249,843     (192)   (104,846)  
Beginning balance (in shares) at Dec. 31, 2021         90,697                
Balance, beginning of period at Dec. 31, 2021 124,978 124,978     $ 9     253,468   (477) (477)   (128,022)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Foreign currency translation adjustment (49)                 (49)      
Stock-based compensation 2,479           2,479            
Net loss (12,987)                     (12,987)  
Net unrealized loss on marketable securities (888)                 (888)      
Ending balance (in shares) at Mar. 31, 2022       90,697                  
Balance, end of period at Mar. 31, 2022 113,533     $ 9     255,947     (1,414)   (141,009)  
Beginning balance (in shares) at Dec. 31, 2021         90,697                
Balance, beginning of period at Dec. 31, 2021 124,978 $ 124,978     $ 9     $ 253,468   (477) $ (477)   $ (128,022)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Foreign currency translation adjustment (202)                        
Net loss (23,767)                        
Net unrealized loss on marketable securities (1,176)                        
Ending balance (in shares) at Jun. 30, 2022       91,547                  
Balance, end of period at Jun. 30, 2022 105,418     $ 9     259,053     (1,855)   (151,789)  
Beginning balance (in shares) at Mar. 31, 2022       90,697                  
Balance, beginning of period at Mar. 31, 2022 113,533     $ 9     255,947     (1,414)   (141,009)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Foreign currency translation adjustment (153)                 (153)      
Stock-based compensation 3,423           3,423            
Net loss (10,780)                     (10,780)  
Net unrealized loss on marketable securities (288)                 (288)      
Gross issuance of shares upon vesting of stock-based awards (n shares)       1,055                  
Shares withheld to cover withholding taxes for stock-based awards (in shares)       (205)                  
Shares withheld to cover employees’ withholding taxes for stock-based awards (317)           (317)            
Ending balance (in shares) at Jun. 30, 2022       91,547                  
Balance, end of period at Jun. 30, 2022 $ 105,418     $ 9     $ 259,053     $ (1,855)   $ (151,789)